PET-CT localizes previously undetectable metastatic lesions in recurrent fallopian tube carcinoma

Gynecol Oncol. 2002 Dec;87(3):323-6. doi: 10.1006/gyno.2002.6841.

Abstract

Background: Fallopian tube carcinoma is a rare malignancy that commonly recurs after initial surgical resection. New combined instrumentation with co-registered PET and CT is a new technique that combines functional and anatomic imaging to detect metastatic disease that may be difficult to detect with either modality alone.

Case: We present two cases of suspected fallopian tube carcinoma recurrence demonstrating the unique potential of combined PET-CT using 18F-fluoro-2-deoxyglucose (FDG). These cases demonstrate the unique capability to detect and localize metastatic disease when serum CA-125, laparoscopy, and CT scan alone were unable to detect recurrence.

Conclusion: PET-CT with FDG may prove to be a sensitive and accurate method for detection of metastatic disease and may influence the clinical management of recurrent fallopian tube carcinoma.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Fallopian Tube Neoplasms / diagnostic imaging*
  • Fallopian Tube Neoplasms / pathology
  • Female
  • Fluorine Radioisotopes
  • Fluorodeoxyglucose F18
  • Humans
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local / diagnostic imaging*
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Staging
  • Radiopharmaceuticals
  • Tomography, Emission-Computed

Substances

  • Fluorine Radioisotopes
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18